Alnylam Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference.
ALNY Key Statistics
Stock Snapshot
As of today, Alnylam Pharmaceuticals(ALNY) shares are valued at $442.70. The company's market cap stands at 58.49B, with a P/E ratio of 1832.32.
As of 2025-11-07, Alnylam Pharmaceuticals(ALNY) stock has fluctuated between $430.84 and $443.59. The current price stands at $442.70, placing the stock +2.8% above today's low and -0.2% off the high.
The Alnylam Pharmaceuticals(ALNY)'s current trading volume is 681.65K, compared to an average daily volume of 1.27M.
In the last year, Alnylam Pharmaceuticals(ALNY) shares hit a 52-week high of $495.55 and a 52-week low of $205.87.
In the last year, Alnylam Pharmaceuticals(ALNY) shares hit a 52-week high of $495.55 and a 52-week low of $205.87.
ALNY News
Alnylam Pharmaceuticals recently reported that third-quarter revenue rose to US$1.25 billion from US$500.92 million a year earlier, swinging from a net loss to...
Wondering if Alnylam Pharmaceuticals is actually good value right now? You are not alone, especially with all the hype and debate around biotech stocks lately....
Goldman Sachs analysts removed Alnylam (ALNY) from the firm’s US Conviction List as part of its monthly update. Elevate Your Investing Strategy: Take advantag...
Analyst ratings
72%
of 32 ratingsMore ALNY News
Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface...
